Ally Bridge Group
3 rounds tracked since 17 March 2026.
- Rounds
- 3
- Led
- 2
- Capital in these rounds
- $455M
Sectors
Countries
Rounds
- AdvanCellLeadDevelops targeted alpha therapies for cancer and expands clinical and commercial manufacturing capacity. $315MSeries D · 15 Jul
- CalyxoLeadDevelops the CVAC system used for treating kidney stone removal in patients. $40MSeries F · 14 Apr
- Imperative CareDevelops neurovascular medical devices for stroke and other vascular conditions. $100M17 Mar
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise